Early Stage, HER2-Positive Breast Cancer Patients At Increased Risk Of Recurrence

[News]

Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center.

More... (http://www.medicalnewstoday.com/articles/133023.php)